UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 1.142

Sortiert nach

Understanding and integrating cytoreductive nephrectomy with immune checkpoint inhibitors in the management of metastatic RCC

Nature reviews. Urology, 2023-11, Vol.20 (11), p.654-668

2023

Link zum Volltext

Verfügbarkeit prüfen

Survival following cytoreductive nephrectomy: a comparison of existing prognostic models

BJU international, 2020-12, Vol.126 (6), p.745-753

2020

Link zum Volltext

Verfügbarkeit prüfen

Models of Renal Cell Carcinoma Used to Investigate Molecular Mechanisms and Develop New Therapeutics

Frontiers in oncology, 2022-04, Vol.12, p.871252-871252

2022

Link zum Volltext

Verfügbarkeit prüfen

Optimizing the diagnosis and management of ductal prostate cancer

Nature reviews. Urology, 2021-06, Vol.18 (6), p.337-358

2021

Link zum Volltext

Verfügbarkeit prüfen

Understanding the Tumor Immune Microenvironment in Renal Cell Carcinoma

Cancers, 2023-04, Vol.15 (9), p.2500

2023

Link zum Volltext

Verfügbarkeit prüfen

Do I need to see a urologist for my vasectomy? A comparison of practice patterns between urologists and family medicine physicians

Asian journal of andrology, 2019-11, Vol.21 (6), p.540-543

2019

Link zum Volltext

Verfügbarkeit prüfen

Non-Metastatic Clear Cell Renal Cell Carcinoma Immune Cell Infiltration Heterogeneity and Prognostic Ability in Patients Following Surgery

Cancers, 2024-01, Vol.16 (3), p.478

2024

Link zum Volltext

Verfügbarkeit prüfen

Genetic Analysis of the Role of yfiR in the Ability of Escherichia coli CFT073 To Control Cellular Cyclic Dimeric GMP Levels and To Persist in the Urinary Tract

Infection and Immunity, 2013-09, Vol.81 (9), p.3089-3098

2013

Link zum Volltext

Verfügbarkeit prüfen

Adjuvant therapy for renal cell carcinoma: Finding the signal in the noise

Urologic oncology, 2024-07

2024

Link zum Volltext

Verfügbarkeit prüfen

Cytoreductive Nephrectomy Following Immune Checkpoint Inhibitor Therapy Is Safe and Facilitates Treatment-free Intervals

European urology open science (Online), 2023-04, Vol.50, p.43-46

2023

Link zum Volltext

Verfügbarkeit prüfen

Focusing on organ preservation and function: paradigm shifts in the treatment of pediatric genitourinary rhabdomyosarcoma

International Urology and Nephrology, 2016-07, Vol.48 (7), p.1009-1013

2016

Link zum Volltext

Verfügbarkeit prüfen

Increased body mass index is associated with operative difficulty during robot‐assisted radical prostatectomy

BJUI compass, 2022-01, Vol.3 (1), p.68-74

2022

Link zum Volltext

Verfügbarkeit prüfen

Does a screening digital rectal exam provide actionable clinical utility in patients with an elevated PSA and positive MRI?

BJUI compass, 2021-05, Vol.2 (3), p.188-193

2021

Link zum Volltext

Verfügbarkeit prüfen

Neddylation inhibition sensitises renal medullary carcinoma tumours to platinum chemotherapy

Clinical and translational medicine, 2023-05, Vol.13 (5), p.e1267-n/a

2023

Link zum Volltext

Verfügbarkeit prüfen

Renal cell carcinoma with isolated lymph node metastases should be reclassified as stage IV

Cancer, 2020-07, Vol.126 (13), p.2965-2967

2020

Link zum Volltext

Verfügbarkeit prüfen

Causal Diagram Techniques for Urologic Oncology Research

Clinical genitourinary cancer, 2021-06, Vol.19 (3), p.271.e1-271.e7

2021

Link zum Volltext

Verfügbarkeit prüfen

Freehand versus Grid-Based Transperineal Prostate Biopsy: A Comparison of Anatomical Region Yield and Complications

The Journal of urology, 2021-10, Vol.206 (4), p.894-902

2021

Link zum Volltext

Verfügbarkeit prüfen

Urosymphyseal Fistulas Resulting From Endoscopic Treatment of Radiation-induced Posterior Urethral Strictures

Urology (Ridgewood, N.J.), 2018-04, Vol.114, p.207-211

2018

Link zum Volltext

Verfügbarkeit prüfen

Shorter Ureters Lead to Fewer Strictures Following Cystectomy and Urinary Diversion

Urology (Ridgewood, N.J.), 2024-02, Vol.184, p.272-277

2024

Link zum Volltext

Verfügbarkeit prüfen

The Impact of Agent Orange Exposure on Non-Muscle Invasive Bladder Cancer Outcomes

Urology (Ridgewood, N.J.), 2023-12, Vol.182, p.175-180

2023

Link zum Volltext

Verfügbarkeit prüfen

Ductal Prostate Cancers Demonstrate Poor Outcomes with Conventional Therapies

European urology, 2021-02, Vol.79 (2), p.298-306

2021

Link zum Volltext

Verfügbarkeit prüfen

Patient selection for cytoreductive nephrectomy in combination with targeted therapies or immune checkpoint inhibitors

Current opinion in urology, 2019-09, Vol.29 (5), p.513

2019

Link zum Volltext

Verfügbarkeit prüfen

Differentiation of benign from malignant solid renal lesions with MRI-based radiomics and machine learning

Abdominal radiology (New York), 2022-08, Vol.47 (8), p.2896-2904

2022

Link zum Volltext

Verfügbarkeit prüfen

Reply to Alireza Ghoreifi and Hooman Djaladat’s Letter to the Editor re: Daniel D. Shapiro, Jose A. Karam, Logan Zemp, et al. Cytoreductive Nephrectomy Following Immune Checkpoint Inhibitor Therapy Is Safe and Facilitates Treatment-free Intervals. Eur Urol Open Sci 2023;50:43–6

European urology, 2023-08, Vol.84 (2), p.e55-e56

2023

Link zum Volltext

Verfügbarkeit prüfen

Contemporary patients have better perioperative outcomes following cytoreductive nephrectomy: a multi-institutional analysis of 1272 consecutive patients

Urology (Ridgewood, N.J.), 2023-12, Vol.182, p.168-174

2023

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 1.142

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.047)
Mit Volltextzugriff
(1.005)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(1.136)
Japanisch
(121)
Französisch
(8)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(18)
... seit 30 Tagen
(12)

Menü

Weitere Dienste

Einstellungen

Understanding and integrating cytoreductive nephrectomy with immune checkpoint inhibitors in the management of metastatic RCC

Survival following cytoreductive nephrectomy: a comparison of existing prognostic models

Models of Renal Cell Carcinoma Used to Investigate Molecular Mechanisms and Develop New Therapeutics

Optimizing the diagnosis and management of ductal prostate cancer

Understanding the Tumor Immune Microenvironment in Renal Cell Carcinoma

Do I need to see a urologist for my vasectomy? A comparison of practice patterns between urologists and family medicine physicians

Non-Metastatic Clear Cell Renal Cell Carcinoma Immune Cell Infiltration Heterogeneity and Prognostic Ability in Patients Following Surgery

Genetic Analysis of the Role of yfiR in the Ability of Escherichia coli CFT073 To Control Cellular Cyclic Dimeric GMP Levels and To Persist in the Urinary Tract

Adjuvant therapy for renal cell carcinoma: Finding the signal in the noise

Cytoreductive Nephrectomy Following Immune Checkpoint Inhibitor Therapy Is Safe and Facilitates Treatment-free Intervals

Focusing on organ preservation and function: paradigm shifts in the treatment of pediatric genitourinary rhabdomyosarcoma

Increased body mass index is associated with operative difficulty during robot‐assisted radical prostatectomy

Does a screening digital rectal exam provide actionable clinical utility in patients with an elevated PSA and positive MRI?

Neddylation inhibition sensitises renal medullary carcinoma tumours to platinum chemotherapy

Renal cell carcinoma with isolated lymph node metastases should be reclassified as stage IV

Causal Diagram Techniques for Urologic Oncology Research

Freehand versus Grid-Based Transperineal Prostate Biopsy: A Comparison of Anatomical Region Yield and Complications

Urosymphyseal Fistulas Resulting From Endoscopic Treatment of Radiation-induced Posterior Urethral Strictures

Shorter Ureters Lead to Fewer Strictures Following Cystectomy and Urinary Diversion

The Impact of Agent Orange Exposure on Non-Muscle Invasive Bladder Cancer Outcomes

Ductal Prostate Cancers Demonstrate Poor Outcomes with Conventional Therapies

Patient selection for cytoreductive nephrectomy in combination with targeted therapies or immune checkpoint inhibitors

Differentiation of benign from malignant solid renal lesions with MRI-based radiomics and machine learning

Reply to Alireza Ghoreifi and Hooman Djaladat’s Letter to the Editor re: Daniel D. Shapiro, Jose A. Karam, Logan Zemp, et al. Cytoreductive Nephrectomy Following Immune Checkpoint Inhibitor Therapy Is Safe and Facilitates Treatment-free Intervals. Eur Urol Open Sci 2023;50:43–6

Contemporary patients have better perioperative outcomes following cytoreductive nephrectomy: a multi-institutional analysis of 1272 consecutive patients

Suchergebnisse filtern